Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20268 Citations
Matrixyl (Pal-KTTKS) is a collagen-signaling peptide backed by a 93-person split-face RCT showing wrinkle reduction at 3 ppm. Moderate clinical evidence, broad community adoption, and one of the best tolerability profiles in topical peptides. Results peak at 12 to 16 weeks.
2mcg · Daily
Summary: Add 0mL BAC water to your 5mg vial. Draw to < 0.1 units on a U-100 syringe for a 2mcg dose. This vial will last 0 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 2mg | Daily |
| Moderate | 5mg | Daily |
| Aggressive | 10mg | Daily |
Matrixyl is topical. No vials, no reconstitution, no syringes. That alone makes it the easiest peptide in most people's stack. The concentration math trips everyone up. "10% Matrixyl complex" on a label does not mean 10% pure peptide. Actual Pal-KTTKS content in a "10% complex" product sits around 0.003 to 0.005% (3 to 5 ppm). The Robinson RCT used just 3 ppm and still hit significance. So those retail numbers are in the therapeutic range; they're just confusingly labeled. For DIY formulators: dissolve raw Pal-KTTKS powder at 0.0003 to 0.0008% w/v in a water and glycerin base. Target pH 5.5 to 6.5. The palmitoyl ester bond is acid-labile below pH 4. Add 0.5% phenoxyethanol plus 0.5% ethylhexylglycerin for preservation. Refrigerate and use within three months. Apply to clean, dry skin. Wait two to three minutes before layering moisturizer. Twice daily, morning and evening. The non-obvious thing most beginners miss: applying over a heavy cream blocks penetration. Matrixyl goes on bare skin, not on top of your routine.
Dosing based on Cosmeceutical industry standard concentrations — 11 published references.View all sources →
Cross-check your Matrixyl reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Matrixyl (Pal-KTTKS) is a collagen-signaling peptide backed by a 93-person split-face RCT showing wrinkle reduction at 3 ppm. Moderate clinical evidence, broad community adoption, and one of the best tolerability profiles in topical peptides. Results peak at 12 to 16 weeks.